How many samples are enough? study aims to perfect breast biopsy technique

NCT ID NCT06062992

Completed Diagnosis Sponsor: Zuyderland Medisch Centrum Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how many tissue samples are needed when doing a special type of breast biopsy called contrast-enhanced stereotactic biopsy (CESB). The biopsy is used for breast lesions that only show up on contrast-enhanced mammography. Researchers studied 77 women to find the minimum number of samples needed for a reliable diagnosis, while also tracking complications and patient comfort.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Contrast Enhanced Stereotactic Biopsy (diagnostic test)
What this could lead to: If successful, this could establish a standard for how many biopsy samples are needed, reducing unnecessary procedures while ensuring accurate diagnosis.
What could go wrong: This is a small, completed study (77 participants) focused on procedure optimization, not a new treatment. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm female breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER BREAST CANCER FEMALE BREAST NEOPLASMS

Contacts and locations

Locations

Zuyderland Medical Center

Sittard, Limburg, 6162BG, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.